Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aspire Biopharma Holdings ( (ASBP) ) has issued an update.
On April 20, 2026, Aspire Biopharma closed the second and final tranche of a previously announced private placement, issuing 12,500 shares of Series A convertible preferred stock for $10 million and bringing total proceeds from the offering to $21 million. The raise lifts stockholders’ equity above the $2.5 million threshold required to maintain its Nasdaq Capital Market listing and will be used for working capital, to fund part of the cash component of the proposed acquisition of Dura Control Systems (DCS), and for general corporate purposes.
The company also secured a commitment letter from a national financial institution for a senior secured credit facility of up to $22.5 million, expected to finance the planned $30 million all-cash purchase of 100% of DCS, a global automotive driver control systems supplier that reported more than $200 million in 2025 revenue and over $20 million in adjusted EBITDA. Together, the equity financing and prospective credit facility underpin Aspire’s dual-track growth strategy of expanding its sublingual drug and supplement platform and BUZZ BOMB retail presence while adding a cash-generative automotive systems business, a combination that could strengthen its financial position and support a more capital-efficient growth model for shareholders.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. is a biopharmaceutical company developing a patent-pending sublingual drug delivery technology designed to deliver therapies rapidly and precisely into the bloodstream, bypassing the gastrointestinal tract. Its platform can be applied to a wide range of active pharmaceutical ingredients, nutraceuticals and supplements, and underpins products such as BUZZ BOMB, an innovative caffeine formulation aimed at consumer and retail markets.
Average Trading Volume: 832,792
Technical Sentiment Signal: Sell
Current Market Cap: $2.74M
Learn more about ASBP stock on TipRanks’ Stock Analysis page.